Skip to main content

Table 5 Multiple tumors in 75 of the 481 index cases

From: Familial cancer among consecutive uterine cancer patients in Sweden

Additional tumors

Of patients with multiple tumors

Of total patient population

Nr in group with other tumors

Other tumors$

Breast cancer (BR)

34/75 (45%)§

34/481 (7%)

7/34

CRC + myeloma, CRC + skin, CRC (2 patients), salivary gland, malignant melanoma, skin

Colorectal cancer (CRC)

14/75 (19%)

14/481 (3%)

6/14

BR + myeloma, BR + skin, BR (2 patients), urinary tract, skin

Ovarian cancer

4/75 (5%)

4/481 (0.4%)

0/4

 

Other cancer*

34/75 (45%)

34/481 (7%)

7/34

Skin (3 patients), myeloma, salivary gland, malignant melanoma, urinary tract.

  1. Note that some patients had more than one additional tumor.
  2. §12/34 (35%) had been treated with selective estrogen receptor modulator therapy.
  3. *11 with skin cancer; 5 malignant melanoma, 4 cervical cancer, 4 lymphoma, 2 myeloma, 2 urinary tract tumors (UT), 1 each of: kidney, central nervous system, lung, extra-adrenal paraganglioma, salivary gland and vocal cord cancer.
  4. $Diagnoses in italics have already been mentioned in the columns above.
Back to article page

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287